The 12 closest competitors and alternatives to Alpheus Medical, Inc. among medical technology companies — ranked by similarity to what Alpheus Medical, Inc. actually does, not by market-cap band.
Subscribe to see Alpheus Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alpheus Medical, Inc. is a privately held biotechnology company based in Chanhassen, Minnesota, focused on developing an investigational therapy that pairs a tumor-accumulating drug with ultrasound.
Alpheus Medical, Inc. is a medical technology company headquartered in United States. It has raised at least $126.5M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $52M in May 2025. Xcout tracks 20 named people at Alpheus Medical, Inc., including Vijay Agarwal (Chief Executive Officer).
14 more named people on record for Alpheus Medical, Inc., with roles, board committees and tenure — see the full roster →
At least $126.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $52M | 7 named | |
| Series B | $60.5M | 7 named | |
| SEC Form D filing | $14M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Alpheus Medical, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Oleander Medical Technologies is developing a cancer treatment called Targeted Osmotic Lysis (TOL), which destroys malignant cells by forcing them to absorb excessive sodium and burst. The therapy combines an existing heart medication with an investigational pulsed electric field device to target cancers with elevated sodium channel expression while leaving healthy cells unharmed.
Biotechnology
Haniva Technology LLC is a biotechnology company that develops patented combination therapies and drug delivery devices to treat various forms of cancer. Its research focuses on using non-thermal plasma alongside hypoxia-activated DNA-damaging agents to selectively target and reduce tumor volume, prevent metastasis, and serve as an adjuvant treatment following tumor resection.
Biotechnology
KAIO Therapy, LLC develops an Immune Activating Heat Therapy (IAHT) technology designed to treat cancer patients by combining hyperthermia with immunotherapy. The system utilizes injected nanoparticles and an alternating magnetic field device to induce controlled heat within tumors, which destroys cancer cells and activates the patient's immune system against primary and metastatic tumors.
Biotech
TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.
Similar medical technology company
Sonex Health, Inc. is a medical device company headquartered in Eagan, Minnesota, that innovates ultrasound-guided procedures and develops proprietary medical instruments such as UltraGuide systems.
Healthtech
FinalDose is a biotechnology research company headquartered in San Francisco, United States. It is developing the first programmable drug platform, which involves a single smart drug molecule designed to find diseased cells by their DNA for cancer therapy.
Similar medical technology company
Pulsify Medical is a cardiovascular medical technology company based in Leuven, Belgium, that develops novel ultrasound solutions and devices.
Healthcare Technology
Hil Applied Medical is a privately held healthcare technology company developing ultra-compact, high-performance proton beam therapy systems for cancer treatment. The company utilizes a patented, laser-based, nanotech-enabled approach originating from technological breakthroughs at the Hebrew University. Headquartered in Jerusalem, Israel, with a North American presence in Reno, Nevada, the company is backed by venture capital and strategic partners.
Healthtech
January Therapeutics, Inc. is a privately held biotechnology company founded in 2017 and based in California, focused on developing next-generation targeted anti-cancer therapies.
Similar medical technology company
Endogenex, Inc. is a privately held, clinical-stage medical device company developing therapeutic devices for metabolic and gastrointestinal conditions. The company is headquartered in Minneapolis, Minnesota, United States.
Therapeutics
Alessa Therapeutics, Inc. is a clinical-stage biotechnology and drug development company headquartered in San Carlos, California, pioneering innovative localized treatments for solid tumors.
Biotechnology
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alpheus Medical, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →